It’s Never Too Early for Cold Chain Planning for Cellular Therapies

October 01, 2016

New cellular therapies underscore the complexity of cold chain logistics with new requirements that may be unfamiliar to even experienced supply chain managers. Writing in Applied Clinical Trials, Tamie Joeckel, senior vice president of client services and consulting for Cryoport, notes that in addition to strict temperature guidelines, these cellular-based therapies have multi-step supply chains that present a new layer of complexity to scheduling, tracking and tracing because the distribution is also extremely time-sensitive. Learn how these challenges are changing both shipping containers and the sophisticated logistics systems that track them. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Frozen Biological Shipping

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC